Erythromycin Tablet, Film Coated
Product Images NDC 70771-1548

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 70771-1548). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

250 mg Label (24a088e5 5eeb 4be9 8d6c 53067262e6c9 01)

Erythromycin Tablets, USP 250 mg film-coated oral tablets label. The label shows the strength as 250 mg and package size of 100 tablets. It is labeled for prescription use only and manufactured by Zydus Lifesciences Limited. The label includes storage instructions, child-resistant packaging notice, and usage guidelines.*

FDA Label Image

500 mg Label (24a088e5 5eeb 4be9 8d6c 53067262e6c9 02)

Label for Erythromycin Tablets, USP 500 mg film-coated oral tablets in a package of 100 tablets. The label includes dosing instructions, storage conditions, child-resistant packaging notice, and states manufacturing by Cadila Healthcare Ltd, Ahmedabad, India. The labeler is Zydus Lifesciences Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.